GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eviana Health Corp (XCNQ:EHC) » Definitions » Interest Coverage

Eviana Health (XCNQ:EHC) Interest Coverage : 0 (At Loss) (As of Mar. 2019)


View and export this data going back to 2017. Start your Free Trial

What is Eviana Health Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Eviana Health's Operating Income for the three months ended in Mar. 2019 was C$-0.67 Mil. Eviana Health's Interest Expense for the three months ended in Mar. 2019 was C$-0.52 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Eviana Health's Interest Coverage or its related term are showing as below:


XCNQ:EHC's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.56
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Eviana Health Interest Coverage Historical Data

The historical data trend for Eviana Health's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Eviana Health Interest Coverage Chart

Eviana Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18
Interest Coverage
No Debt No Debt N/A N/A

Eviana Health Quarterly Data
Jun15 Mar16 Jun16 Sep16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only No Debt N/A N/A - -

Competitive Comparison of Eviana Health's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Eviana Health's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eviana Health's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eviana Health's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Eviana Health's Interest Coverage falls into.



Eviana Health Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Eviana Health's Interest Coverage for the fiscal year that ended in Jun. 2018 is calculated as

Here, for the fiscal year that ended in Jun. 2018, Eviana Health's Interest Expense was C$0.00 Mil. Its Operating Income was C$-4.41 Mil. And its Long-Term Debt & Capital Lease Obligation was C$0.02 Mil.

GuruFocus does not calculate Eviana Health's interest coverage with the available data.

Eviana Health's Interest Coverage for the quarter that ended in Mar. 2019 is calculated as

Here, for the three months ended in Mar. 2019, Eviana Health's Interest Expense was C$-0.52 Mil. Its Operating Income was C$-0.67 Mil. And its Long-Term Debt & Capital Lease Obligation was C$8.02 Mil.

Eviana Health did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Eviana Health  (XCNQ:EHC) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Eviana Health Interest Coverage Related Terms

Thank you for viewing the detailed overview of Eviana Health's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Eviana Health (XCNQ:EHC) Business Description

Traded in Other Exchanges
N/A
Address
5728 East Boulevard, Vancouver, BC, CAN, V6M 4M4
Eviana Health Corp produces and sells cannabinoid products from natural hemp strains of cannabis sativa for consumer health-care products, pharmaceuticals, nutraceuticals, and cosmeceuticals, as well as for topical creams and other health and wellness products.
Executives
Olivier Robert Francis Benloulou 10% Security Holder